About 500 reports

AND GOODERHAM, M. (2017) ' PSORIASIS, DEPRESSION, AND SUICIDALITY. ', SKIN THERAPY LETTER, ##(##), PP. ##-##.

  • E-Healthcare
  • Immunotherapy
  • Injectable Delivery
  • Novartis AG
  • Pfizer Inc.
  • 5.2 GLOBAL TELEMEDICINE - GYNECOLOGY MARKET AND FORECAST
  • 3.2 GLOBAL TELEHOME MARKET AND FORECAST

Postpartum depression: Offering convenient access for women suffering from postpartum depression is an essential part of providing perinatal care as an OB/ GYN (Obstetriciangynecologists).

  • E-Healthcare
  • World
  • Market Size
  • Allscripts Healthcare Solutions, Inc.
  • Cerner Corporation

For the ## million Americans who have clinical depression, roughly one third don' t find relief with antidepressants.

  • E-Healthcare
  • Immunotherapy
  • Injectable Delivery
  • Therapy
  • Mallinckrodt plc

This can lead to negative selfimage and mental health disorders such as anxiety and depression.

  • Immunotherapy
  • Injectable Delivery
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation

DEPRESSION IS ONE OF THE LEADING CAUSES OF DISABILITY IN THE UNITED STATES.

  • E-Healthcare
  • Injectable Delivery
  • Australasia
  • Australia
  • Oceania

TABLE ##.

  • E-Healthcare
  • Immunotherapy
  • Injectable Delivery
  • Forecast
  • Market Size
  • Facial Injectables Market: Revenue in USD million, Hyaluronic Acid, Global, 2016-2024
  • BY APPLICATION

These fillers are safe and are well tolerated, with great results to fill the depression associated with scars.

  • Body Care
  • E-Healthcare
  • Injectable Delivery
  • Personal Hygiene
  • Skin Care
  • SAFETY RESULTS FOR OCREVUS IN PHASE III (OPERA I AND OPERA II) MS TRIALS

Multiple sclerosis beyond EDSS: depression and fatigue.

  • E-Healthcare
  • Immunotherapy
  • Injectable Delivery
  • Monoclonal Antibody
  • Therapy

Food and Drug Administration (FDA) has approved SPRAVATO (esketamine) CIII nasal spray for use in conjunction with an oral antidepressant in adults with treatmentresistant depression (TRD).

  • E-Healthcare
  • Immunotherapy
  • Injectable Delivery
  • Forecast
  • Market Size
  • MARKET OUTLINE
  • MARKET CHALLENGES

Strength: ## Low; ## High Assessment B.

  • Analgesic
  • Drug Delivery
  • E-Healthcare
  • Injectable Delivery
  • Therapy

THREATS OF SUBSTITUTES - LOW ##.

  • E-Healthcare
  • Injectable Delivery
  • World
  • Market Size
  • B. Braun Medical
  • 9.9 INCREASING ACCEPTANCE OF TELEMEDICINE BY PATIENTS
  • 3.2 GLOBAL TELEHOME MARKET AND FORECAST

Telecom and Networking ##.

  • E-Healthcare
  • World
  • Cerner Corporation
  • GE Healthcare Limited
  • McKesson Corporation

OTHER SIDE EFFECTS OF REMICADE INCLUDE NAUSEA, ABDOMINAL PAIN, WORSENING HEART FAILURE, HYPERSENSITIVITY REACTIONS, FEVER, HEADACHE, DEPRESSION, AND ##. ##. ## SAFETY the formation of anti-TNF-α antibodies (Rutgeerts et al., 2005).

  • E-Healthcare
  • Immunotherapy
  • Injectable Delivery
  • AbbVie Inc.
  • Pfizer Inc.

THIS IS UTILIZED TO TREAT NEUROLOGICAL DISORDERS LIKE EPILEPSY AND DEPRESSION.

  • E-Healthcare
  • Injectable Delivery
  • Brazil
  • South America
  • Medtronic, Inc.

THIS IS UTILIZED TO TREAT NEUROLOGICAL DISORDERS LIKE EPILEPSY AND DEPRESSION.

  • Injectable Delivery
  • Latin America
  • Mexico
  • North America
  • Medtronic, Inc.
  • Global home healthcare market by preventive care 2016-2021 ($ billions)

You can easily book an appointment with one online.

  • E-Healthcare
  • Healthcare
  • Home Healthcare
  • Hospital
  • Injectable Delivery

NICE SAYS DEPREXIS COULD BE AN EFFECTIVE ALTERNATIVE THERAPY FOR ADULTS WITH MILD TO MODERATE DEPRESSION.

  • E-Healthcare
  • Immunotherapy
  • Injectable Delivery
  • Northern Europe
  • United Kingdom

US Telemental Health Market, Forecast to 2021 ##.

  • E-Healthcare
  • Telemedicine
  • United States
  • Forecast
  • Market Size

THIS IS UTILIZED TO TREAT NEUROLOGICAL DISORDERS LIKE EPILEPSY AND DEPRESSION.

  • E-Healthcare
  • Injectable Delivery
  • India
  • South Asia
  • Medtronic, Inc.

THIS IS UTILIZED TO TREAT NEUROLOGICAL DISORDERS LIKE EPILEPSY AND DEPRESSION.

  • E-Healthcare
  • Injectable Delivery
  • Italy
  • Southern Europe
  • Medtronic, Inc.

Food and Drug Administration (FDA) has approved SPRAVATO (esketamine) CIII nasal spray for use in conjunction with an oral antidepressant in adults with treatment-resistant depression (TRD).

  • E-Healthcare
  • Immunotherapy
  • Injectable Delivery
  • North America
  • Market Size

THIS IS UTILIZED TO TREAT NEUROLOGICAL DISORDERS LIKE EPILEPSY AND DEPRESSION.

  • E-Healthcare
  • Injectable Delivery
  • East Asia
  • South Korea
  • Medtronic, Inc.

THIS IS UTILIZED TO TREAT NEUROLOGICAL DISORDERS LIKE EPILEPSY AND DEPRESSION.

  • Injectable Delivery
  • Eastern Europe
  • Russia
  • B. Braun Melsungen AG
  • Medtronic, Inc.

THIS IS UTILIZED TO TREAT NEUROLOGICAL DISORDERS LIKE EPILEPSY AND DEPRESSION.

  • Injectable Delivery
  • Southern Europe
  • Spain
  • B. Braun Melsungen AG
  • Medtronic, Inc.
  • 7. PEN NEEDLES MARKET ANALYSIS- BY TYPE

OBESITY IS ONE OF THE TOP FIVE RISK FACTORS FOR EARLY DEATH.

  • Injectable Delivery
  • World
  • Forecast
  • Market Size
  • Artsana S.p.A.

The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study.

  • Immunotherapy
  • Injectable Delivery
  • Market Size
  • AbbVie Inc.
  • Janssen Biotech, Inc.

One unit refers to one CDU.

  • E-Healthcare
  • Injectable Delivery
  • Canada
  • Getinge Group
  • LivaNova PLC

ONE UNIT REFERS TO ONE CDU.

  • Injectable Delivery
  • Market Size
  • Braile Biomedica Ltda.
  • Getinge Group
  • LivaNova PLC
  • 7.2.1 INCREASING USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE

Rare AEs include hepatitis, depression and temporary male infertility.

  • Immunotherapy
  • Injectable Delivery
  • AbbVie Inc.
  • Galapagos NV
  • Pfizer Inc.
  • 2.3.2 Acne Vulgaris

Acne Vulgaris and Depression: A Retrospective Examination.

  • Immunotherapy
  • Injectable Delivery
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.